Breedit Corp. (BRDT) 0.0650 $BRDT
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
BreedIT Corp Subsidiary Signs Pilot Agreement for its Mobile Application with Vilmorin & Cie
PR Newswire - Thu Jan 29, 6:00AM CST
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, today announced that it has entered into a pilot agreement for its BreedIT Mobile(TM) with Vilmorin & Cie (RIN:FP ).
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
BreedIT and Seach Leverage Designer Strains to Better Cure
ACCESSWIRE - Thu Dec 18, 8:40AM CST
WHITEFISH, MT / ACCESSWIRE / December 18, 2014 / The benefits of medical cannabis are becoming increasingly apparent as companies like GW Pharmaceuticals plc (NASDAQ: GWPH) publish the results of the clinical trials for their cannabinoid-based medicines. For example, their Epidiolex has shown tremendous potential in treating Dravet and Lennox-Gastaut syndromes.
GWPH: 78.09 (+1.70)
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06)
BreedIT Corp Submits First Two Proprietary Medical Cannabis Strains for Registration With Israel's Ministry of Agriculture
PR Newswire - Tue Dec 02, 7:45AM CST
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, today announced that its joint venture, KanaboSeed Ltd., has submitted applications for the registration of two new cannabis strains to the Israeli Ministry of Agriculture & Rural Development Plant Breeders' Rights Council.
Cannabis Stocks Regain Ground Last Week Ahead of Elections
ACCESSWIRE - Mon Oct 27, 9:00AM CDT
Whitefish, MT / ACCESSWIRE / October 27, 2014 / Cannabis stocks gained ground last week, led by a ~15% recovery in shares of GW Pharmaceuticals plc (NASDAQ: GWPH). MedBox Inc. (OTC: MDBX) shares also rose more than 25%, sending the overall Marijuana Index(TM) significantly higher for the week. Traders will be watching for a continuation of these trends into this week, although a lot may depend on the movements of the larger overall market.
GWPH: 78.09 (+1.70)
BreedIT Corp. CFO Discusses Company's Activities in Medical Cannabis During Interview on CEOLIVE.TV
PR Newswire - Fri Oct 17, 7:30AM CDT
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers (collectively "BreedIT or the "Company"
, today announced that its Chief Financial Officer, Oded Gilboa, will be featured in an interview on CEOLIVE.TV, scheduled to air on October 17 2014 at 9:00 am EDT. The interview will then be available at the following web link: http://ceolive.tv/breedit/brdt-videos/2346-ce...otcqb-brdt
BreedIT Corp. Presenting at Marijuana for Medical Professionals Conference in Denver, Colorado
PR Newswire - Tue Sep 09, 7:30AM CDT
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated Intelligent Decision Support Software (IDSS) platform for plant breeders and researchers, today announced that Dr. Oded Sagee will give a private lecture on breeding of new strains of medical cannabis at the upcoming Marijuana For Medical Professionals Conference in Denver, Colorado. The presentation will be made on Tuesday, September 9th, 2014 at 5:00 PM (Mountain Time) at the Sherman Street Event Center.
BreedIT, Monsanto and GW Pharma Underscoring Advancements in Medical Marijuana Industry
ACCESSWIRE - Thu Sep 04, 8:29AM CDT
Whitefish, MT / September 4, 2014 / There is no shortage of philosophies coming from so-called pundits on how to play the legalized marijuana movement. The problem is that it's a nascent industry full of nascent companies, making it difficult to discern which companies will prevail. Many jumping into the pot space are throwing a dart of momentum plays (mostly those in the competitive growing or retail businesses) with only a modicum of information. There are some sectors that are being somewhat overlooked that may offer a more fundamentally sound opportunity for growth. The biotech space is like stacking speculation (biotech) on top of risk (medical marijuana), but that usually adds up to a home run if a company can get it right. Most investors are aware of the potential regulatory hurdles, but that has not steered them away from GW Pharmaceuticals (NASDAQ: GWPH). Probably the best biotech working with cannibinoids, GW Pharma has caught the attention of Wall Street for many reasons, including an upcoming clinical trial for Dravet syndrome, a terrible, life-threatening disease where patients are plagued with seizures that many families argue cannabis provides relief (if not essentially a cure).
SYT: 70.02 (+0.31), MON: 124.77 (+2.00), GWPH: 78.09 (+1.70), AEGN: 17.13 (+0.47)
Link to Interview by CEOLIVE.TV of BreedIT Corp.'s Scientific Advisory Board Chairman, Dr. Alan Shackelford
PR Newswire - Wed Sep 03, 8:00AM CDT
The interview can now be viewed at the following web link http://www.brdt.us/news-media/media/56-dr-ala...ceolive-tv
BreedIT Scientific Advisor, Dr. Alan Shackelford, Interviewed by CEOLIVE.TV
PR Newswire - Tue Sep 02, 7:30AM CDT
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, is pleased to announce that BreedIT Scientific Advisor Dr. Alan Shackelford has been featured in an interview by CEOLIVE.TV. The interview is scheduled to be published on Wednesday, September 3.
117 Marijuana Stocks For Your Do Not 'Buy-And-Hold' List
Anthony Cataldo - at Seeking Alpha - Fri Feb 06, 10:14AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
99 Marijuana Stocks For Your Do Not 'Buy And Hold' List
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 6:25AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03), ICN: 21.26 (-0.05)
Marijuana Firms - Exploring N=99, Ranked By Market Capitalization
Anthony Cataldo - at Seeking Alpha - Mon Feb 02, 3:34AM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
BreedIT Corp Subsidiary Signs Pilot Agreement for its Mobile Application with Vilmorin & Cie
PR Newswire - Thu Jan 29, 6:00AM CST
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, today announced that it has entered into a pilot agreement for its BreedIT Mobile(TM) with Vilmorin & Cie (RIN:FP ).
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VIII
Anthony Cataldo - at Seeking Alpha - Wed Jan 28, 6:48AM CST
GWPH: 78.09 (+1.70), DE: 90.04 (+0.67), FULL: 4.40 (+0.06), CARA: 10.96 (-0.03)
BreedIT and Seach Leverage Designer Strains to Better Cure
ACCESSWIRE - Thu Dec 18, 8:40AM CST
WHITEFISH, MT / ACCESSWIRE / December 18, 2014 / The benefits of medical cannabis are becoming increasingly apparent as companies like GW Pharmaceuticals plc (NASDAQ: GWPH) publish the results of the clinical trials for their cannabinoid-based medicines. For example, their Epidiolex has shown tremendous potential in treating Dravet and Lennox-Gastaut syndromes.
GWPH: 78.09 (+1.70)
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06)
BreedIT Corp Submits First Two Proprietary Medical Cannabis Strains for Registration With Israel's Ministry of Agriculture
PR Newswire - Tue Dec 02, 7:45AM CST
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, today announced that its joint venture, KanaboSeed Ltd., has submitted applications for the registration of two new cannabis strains to the Israeli Ministry of Agriculture & Rural Development Plant Breeders' Rights Council.
Cannabis Stocks Regain Ground Last Week Ahead of Elections
ACCESSWIRE - Mon Oct 27, 9:00AM CDT
Whitefish, MT / ACCESSWIRE / October 27, 2014 / Cannabis stocks gained ground last week, led by a ~15% recovery in shares of GW Pharmaceuticals plc (NASDAQ: GWPH). MedBox Inc. (OTC: MDBX) shares also rose more than 25%, sending the overall Marijuana Index(TM) significantly higher for the week. Traders will be watching for a continuation of these trends into this week, although a lot may depend on the movements of the larger overall market.
GWPH: 78.09 (+1.70)
BreedIT Corp. CFO Discusses Company's Activities in Medical Cannabis During Interview on CEOLIVE.TV
PR Newswire - Fri Oct 17, 7:30AM CDT
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers (collectively "BreedIT or the "Company"
, today announced that its Chief Financial Officer, Oded Gilboa, will be featured in an interview on CEOLIVE.TV, scheduled to air on October 17 2014 at 9:00 am EDT. The interview will then be available at the following web link: http://ceolive.tv/breedit/brdt-videos/2346-ce...otcqb-brdt BreedIT Corp. Presenting at Marijuana for Medical Professionals Conference in Denver, Colorado
PR Newswire - Tue Sep 09, 7:30AM CDT
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated Intelligent Decision Support Software (IDSS) platform for plant breeders and researchers, today announced that Dr. Oded Sagee will give a private lecture on breeding of new strains of medical cannabis at the upcoming Marijuana For Medical Professionals Conference in Denver, Colorado. The presentation will be made on Tuesday, September 9th, 2014 at 5:00 PM (Mountain Time) at the Sherman Street Event Center.
BreedIT, Monsanto and GW Pharma Underscoring Advancements in Medical Marijuana Industry
ACCESSWIRE - Thu Sep 04, 8:29AM CDT
Whitefish, MT / September 4, 2014 / There is no shortage of philosophies coming from so-called pundits on how to play the legalized marijuana movement. The problem is that it's a nascent industry full of nascent companies, making it difficult to discern which companies will prevail. Many jumping into the pot space are throwing a dart of momentum plays (mostly those in the competitive growing or retail businesses) with only a modicum of information. There are some sectors that are being somewhat overlooked that may offer a more fundamentally sound opportunity for growth. The biotech space is like stacking speculation (biotech) on top of risk (medical marijuana), but that usually adds up to a home run if a company can get it right. Most investors are aware of the potential regulatory hurdles, but that has not steered them away from GW Pharmaceuticals (NASDAQ: GWPH). Probably the best biotech working with cannibinoids, GW Pharma has caught the attention of Wall Street for many reasons, including an upcoming clinical trial for Dravet syndrome, a terrible, life-threatening disease where patients are plagued with seizures that many families argue cannabis provides relief (if not essentially a cure).
SYT: 70.02 (+0.31), MON: 124.77 (+2.00), GWPH: 78.09 (+1.70), AEGN: 17.13 (+0.47)
Link to Interview by CEOLIVE.TV of BreedIT Corp.'s Scientific Advisory Board Chairman, Dr. Alan Shackelford
PR Newswire - Wed Sep 03, 8:00AM CDT
The interview can now be viewed at the following web link http://www.brdt.us/news-media/media/56-dr-ala...ceolive-tv
BreedIT Scientific Advisor, Dr. Alan Shackelford, Interviewed by CEOLIVE.TV
PR Newswire - Tue Sep 02, 7:30AM CDT
BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, is pleased to announce that BreedIT Scientific Advisor Dr. Alan Shackelford has been featured in an interview by CEOLIVE.TV. The interview is scheduled to be published on Wednesday, September 3.
